Nonpeptidic HIV protease inhibitors: 3-(S-benzyl substituted)-4-hydroxy-6-(phenyl substituted)-2H-pyran-2-one with an inverse mode of binding
J. V. N. Vara Prasad(Pfizer (United States)), Donna Ferguson(Pfizer (United States)), Peter J. Tummino(Intarcia Therapeutics (United States)), A.G. Pavlovsky(Pfizer (United States)), Kimberly S. Para(Pfizer (United States)), Carolyn Nouhan(Pfizer (United States)), Edmund L. Ellsworth(Pfizer (United States))
Cited by 16
Related Papers
Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori
|Nature|1999|1.9k
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
|Nature|2012|1.8k
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
|Journal of Biological Chemistry|2002|1.4k
Residence Time of Receptor−Ligand Complexes and Its Effect on Biological Function
|Biochemistry|2008|550